{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:19:40Z","timestamp":1790734780891,"version":"4.1.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 AI007110"],"award-info":[{"award-number":["T32 AI007110"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM155229"],"award-info":[{"award-number":["R35GM155229"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32038-2","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T07:46:59Z","timestamp":1766735219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Trimethylamine-N-oxide promotes fibrotic activation of quiescent valvular interstitial cells via endoplasmic reticulum stress"],"prefix":"10.1038","volume":"16","author":[{"given":"Samanvitha","family":"Sudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Drishya","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanmayee","family":"Kolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen Mancera","family":"Azamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniyah","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mohammadalizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Porras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"key":"32038_CR1","doi-asserted-by":"publisher","first-page":"1003233","DOI":"10.3389\/fcvm.2022.1003233","volume":"9","author":"J Yu","year":"2022","unstructured":"Yu, J. et al. Global burden of calcific aortic valve disease and attributable risk factors from 1990 to 2019. Front. Cardiovasc. Med. 9, 1003233 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"32038_CR2","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.3390\/jcm12062178","volume":"12","author":"G Santangelo","year":"2023","unstructured":"Santangelo, G. et al. The global burden of valvular heart disease: From clinical epidemiology to management. JCM 12, 2178 (2023).","journal-title":"JCM"},{"key":"32038_CR3","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.015921","volume":"9","author":"V Kumar","year":"2020","unstructured":"Kumar, V., Sandhu, G. S., Harper, C. M., Ting, H. H. & Rihal, C. S. Transcatheter aortic valve replacement programs: Clinical outcomes and developments. J. Am. Heart Assoc. 9, e015921 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"32038_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCRESAHA.120.316242","volume":"127","author":"M Witkowski","year":"2020","unstructured":"Witkowski, M., Weeks, T. L. & Hazen, S. L. Gut microbiota and cardiovascular disease. Circ. Res. 127, 553\u2013570 (2020).","journal-title":"Circ. Res."},{"key":"32038_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102649","volume":"52","author":"M Tr\u00f8seid","year":"2020","unstructured":"Tr\u00f8seid, M., Andersen, G. \u00d8., Broch, K. & Hov, J. R. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions. EBioMedicine 52, 102649 (2020).","journal-title":"EBioMedicine"},{"key":"32038_CR6","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","volume":"8","author":"Z Jie","year":"2017","unstructured":"Jie, Z. et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 8, 845 (2017).","journal-title":"Nat. Commun."},{"key":"32038_CR7","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/CM9.0000000000002206","volume":"136","author":"X Chen","year":"2023","unstructured":"Chen, X. et al. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases. Chin. Med. J. 136, 2269\u20132284 (2023).","journal-title":"Chin. Med. J."},{"key":"32038_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121947","volume":"329","author":"M Hemmati","year":"2023","unstructured":"Hemmati, M. et al. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD). Life Sci. 329, 121947 (2023).","journal-title":"Life Sci."},{"key":"32038_CR9","doi-asserted-by":"publisher","first-page":"1085041","DOI":"10.3389\/fendo.2023.1085041","volume":"14","author":"J Zhen","year":"2023","unstructured":"Zhen, J. et al. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases. Front. Endocrinol. 14, 1085041 (2023).","journal-title":"Front. Endocrinol."},{"key":"32038_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"32038_CR11","first-page":"240","volume":"25","author":"L Jing","year":"2024","unstructured":"Jing, L. et al. Role of trimethylamine N-Oxide in heart failure. RCM 25, 240 (2024).","journal-title":"RCM"},{"key":"32038_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"32038_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40168-017-0271-9","volume":"5","author":"S Rath","year":"2017","unstructured":"Rath, S., Heidrich, B., Pieper, D. H. & Vital, M. Uncovering the trimethylamine-producing bacteria of the human gut microbiota. Microbiome 5, 54 (2017).","journal-title":"Microbiome"},{"key":"32038_CR14","unstructured":"Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. https:\/\/www.pnas.org\/doi\/epdf\/10.1073\/pnas.1316569111 10.1073\/pnas.1316569111"},{"key":"32038_CR15","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/jth.14234","volume":"16","author":"W Zhu","year":"2018","unstructured":"Zhu, W. et al. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk. J. Thromb. Haemost. 16, 1857\u20131872 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"32038_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett, B. J. et al. Trimethylamine-N-Oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell. Metab. 17, 49\u201360 (2013).","journal-title":"Cell. Metab."},{"key":"32038_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/hmg\/7.5.839","volume":"7","author":"E Treacy","year":"1998","unstructured":"Treacy, E. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum. Mol. Genet. 7, 839\u2013845 (1998).","journal-title":"Hum. Mol. Genet."},{"key":"32038_CR18","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004947","volume":"6","author":"Y Heianza","year":"2017","unstructured":"Heianza, Y., Ma, W., Manson, J. E., Rexrode, K. M. & Qi, L. Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: A systematic review and meta-analysis of prospective studies. J. Am. Heart Assoc. 6, e004947 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"32038_CR19","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jacc.2019.11.060","volume":"75","author":"Y Heianza","year":"2020","unstructured":"Heianza, Y. et al. Long-Term changes in gut microbial metabolite trimethylamine N-Oxide and coronary heart disease risk. J. Am. Coll. Cardiol. 75, 763\u2013772 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"32038_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s13098-024-01368-y","volume":"16","author":"S Naghipour","year":"2024","unstructured":"Naghipour, S. et al. Circulating TMAO, the gut microbiome and cardiometabolic disease risk: An exploration in key precursor disorders. Diabetol. Metab. Syndr. 16, 133 (2024).","journal-title":"Diabetol. Metab. Syndr."},{"key":"32038_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge, X. et al. The gut microbial metabolite trimethylamine n-oxide and hypertension risk: A systematic review and dose-response meta-analysis. Adv. Nutr. 11, 66\u201376 (2020).","journal-title":"Adv. Nutr."},{"key":"32038_CR22","doi-asserted-by":"publisher","first-page":"e020646","DOI":"10.1161\/JAHA.120.020646","volume":"10","author":"Y Lee","year":"2021","unstructured":"Lee, Y. et al. Longitudinal plasma measures of trimethylamine n-oxide and risk of atherosclerotic cardiovascular disease events in community-based older adults. JAHA 10, e020646 (2021).","journal-title":"JAHA"},{"key":"32038_CR23","doi-asserted-by":"publisher","first-page":"6582","DOI":"10.1002\/jcp.29518","volume":"235","author":"P Wu","year":"2020","unstructured":"Wu, P. et al. Trimethylamine N-oxide promotes apoE\u2212\/\u2212 mice atherosclerosis by inducing vascular endothelial cell pyroptosis via the SDHB\/ROS pathway. J. Cell. Physiol. 235, 6582\u20136591 (2020).","journal-title":"J. Cell. Physiol."},{"key":"32038_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.thromres.2019.02.028","volume":"177","author":"X Cheng","year":"2019","unstructured":"Cheng, X., Qiu, X., Liu, Y., Yuan, C. & Yang, X. Trimethylamine N-oxide promotes tissue factor expression and activity in vascular endothelial cells: A new link between trimethylamine N-oxide and atherosclerotic thrombosis. Thromb. Res. 177, 110\u2013116 (2019).","journal-title":"Thromb. Res."},{"key":"32038_CR25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/cells11020204","volume":"11","author":"R Catar","year":"2022","unstructured":"Catar, R. et al. Native and oxidized low-density lipoproteins increase the expression of the LDL Receptor and the LOX-1 Receptor, respectively, in arterial endothelial cells. Cells 11, 204 (2022).","journal-title":"Cells"},{"key":"32038_CR26","doi-asserted-by":"publisher","first-page":"1900514","DOI":"10.1002\/mnfr.201900514","volume":"63","author":"Y-C Koh","year":"2019","unstructured":"Koh, Y.-C. et al. Prevention of vascular inflammation by pterostilbene via trimethylamine-N-Oxide reduction and mechanism of microbiota regulation. Mol. Nutr. Food Res. 63, 1900514 (2019).","journal-title":"Mol. Nutr. Food Res."},{"key":"32038_CR27","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng, J. et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed. Pharmacother. 97, 941\u2013947 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"32038_CR28","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3389\/fphys.2019.00866","volume":"10","author":"X Li","year":"2019","unstructured":"Li, X. et al. Trimethylamine N-Oxide exacerbates cardiac fibrosis via activating the NLRP3 inflammasome. Front. Physiol. 10, 866 (2019).","journal-title":"Front. Physiol."},{"key":"32038_CR29","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3390\/life14040527","volume":"14","author":"G Nayak","year":"2024","unstructured":"Nayak, G. et al. Gut microbiome and Its role in valvular heart disease: not a \u201cGutted\u201d relationship. Life 14, 527 (2024).","journal-title":"Life"},{"key":"32038_CR30","doi-asserted-by":"publisher","first-page":"117431","DOI":"10.1016\/j.atherosclerosis.2023.117431","volume":"391","author":"Z Xiong","year":"2024","unstructured":"Xiong, Z. et al. The gut microbe-derived metabolite trimethylamine-N-oxide induces aortic valve fibrosis via PERK\/ATF-4 and IRE-1\u03b1\/XBP-1s signaling in vitro and in vivo. Atherosclerosis 391, 117431 (2024).","journal-title":"Atherosclerosis"},{"key":"32038_CR31","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1093\/cvr\/cvab243","volume":"118","author":"J Li","year":"2022","unstructured":"Li, J. et al. Trimethylamine N-oxide induces osteogenic responses in human aortic valve interstitial cells in vitro and aggravates aortic valve lesions in mice. Cardiovasc. Res. 118, 2018\u20132030 (2022).","journal-title":"Cardiovasc. Res."},{"key":"32038_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3390\/jcm12020407","volume":"12","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Trimethylamine N-Oxide levels are associated with severe aortic stenosis and predict long-term adverse outcome. JCM 12, 407 (2023).","journal-title":"JCM"},{"key":"32038_CR33","doi-asserted-by":"publisher","first-page":"006339","DOI":"10.1161\/JAHA.117.006339","volume":"6","author":"A Rutkovskiy","year":"2017","unstructured":"Rutkovskiy, A. et al. Valve interstitial cells: The key to understanding the pathophysiology of heart valve calcification. JAHA 6, 006339 (2017).","journal-title":"JAHA"},{"key":"32038_CR34","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1098\/rstb.2007.2126","volume":"362","author":"AH Chester","year":"2007","unstructured":"Chester, A. H. & Taylor, P. M. Molecular and functional characteristics of heart-valve interstitial cells. Phil. Trans. R. Soc. B 362, 1437\u20131443 (2007).","journal-title":"Phil. Trans. R. Soc. B"},{"key":"32038_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2353\/ajpath.2007.070251","volume":"171","author":"AC Liu","year":"2007","unstructured":"Liu, A. C., Joag, V. R. & Gotlieb, A. I. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am. J. Pathol. 171, 1407\u20131418 (2007).","journal-title":"Am. J. Pathol."},{"key":"32038_CR36","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tice.2018.07.004","volume":"54","author":"MS Ali","year":"2018","unstructured":"Ali, M. S. et al. Correlation between valvular interstitial cell morphology and phenotypes: A novel way to detect activation. Tissue Cell 54, 38\u201346 (2018).","journal-title":"Tissue Cell"},{"key":"32038_CR37","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.biomaterials.2017.03.040","volume":"131","author":"H Ma","year":"2017","unstructured":"Ma, H., Killaars, A. R., DelRio, F. W., Yang, C. & Anseth, K. S. Myofibroblastic activation of valvular interstitial cells is modulated by spatial variations in matrix elasticity and its organization. Biomaterial 131, 131\u2013144 (2017).","journal-title":"Biomaterial"},{"key":"32038_CR38","doi-asserted-by":"publisher","first-page":"005041","DOI":"10.1161\/JAHA.116.005041","volume":"6","author":"AM Porras","year":"2017","unstructured":"Porras, A. M. et al. Robust generation of quiescent porcine valvular interstitial cell cultures. J. Am. Heart Assoc. 6, 005041 (2017).","journal-title":"J. Am. Heart Assoc."},{"key":"32038_CR39","doi-asserted-by":"publisher","first-page":"20190103","DOI":"10.1084\/jem.20190103","volume":"217","author":"NG Frangogiannis","year":"2020","unstructured":"Frangogiannis, N. G. Transforming growth factor\u2013\u03b2 in tissue fibrosis. J. Exp. Med. 217, 20190103 (2020).","journal-title":"J. Exp. Med."},{"key":"32038_CR40","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1161\/ATVBAHA.118.310870","volume":"38","author":"H Hirai","year":"2018","unstructured":"Hirai, H. et al. Direct reprogramming of fibroblasts into smooth muscle-like cells with defined transcription factors\u2014brief report. ATVB 38, 2191\u20132197 (2018).","journal-title":"ATVB"},{"key":"32038_CR41","doi-asserted-by":"publisher","first-page":"1296455","DOI":"10.3389\/fncel.2023.1296455","volume":"17","author":"M Chmelova","year":"2023","unstructured":"Chmelova, M. et al. A view of the genetic and proteomic profile of extracellular matrix molecules in aging and stroke. Front. Cell. Neurosci. 17, 1296455 (2023).","journal-title":"Front. Cell. Neurosci."},{"key":"32038_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/01.RES.0000136520.07995.aa","volume":"95","author":"GA Walker","year":"2004","unstructured":"Walker, G. A., Masters, K. S., Shah, D. N., Anseth, K. S. & Leinwand, L. A. Valvular myofibroblast activation by transforming growth factor-\u03b2. Circ. Res. 95, 253\u2013260 (2004).","journal-title":"Circ. Res."},{"key":"32038_CR43","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.110.006767","volume":"124","author":"NM Rajamannan","year":"2011","unstructured":"Rajamannan, N. M. et al. Calcific aortic valve disease: Not simply a degenerative process: a review and agenda for research from the national heart and lung and blood institute aortic stenosis working group executive summary: calcific aortic valve disease \u2013 2011 update. Circulation 124, 1783\u20131791 (2011).","journal-title":"Circulation"},{"key":"32038_CR44","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cjco.2024.06.002","volume":"6","author":"E Le Nezet","year":"2024","unstructured":"Le Nezet, E., Marqueze-Pouey, C., Guisle, I. & Clavel, M.-A. Molecular features of calcific aortic stenosis in female and male patients. CJC Open 6, 1125\u20131137 (2024).","journal-title":"CJC Open"},{"key":"32038_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.747714","volume":"13","author":"VA Myasoedova","year":"2022","unstructured":"Myasoedova, V. A. et al. Sex-specific cell types and molecular pathways indicate fibro-calcific aortic valve stenosis. Front. Immunol. 13, 747714 (2022).","journal-title":"Front. Immunol."},{"key":"32038_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039980","volume":"7","author":"CM McCoy","year":"2012","unstructured":"McCoy, C. M., Nicholas, D. Q. & Masters, K. S. Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS ONE 7, e39980 (2012).","journal-title":"PLoS ONE"},{"key":"32038_CR47","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s00380-022-02164-2","volume":"38","author":"LR Simon","year":"2023","unstructured":"Simon, L. R., Scott, A. J., Figueroa Rios, L., Zembles, J. & Masters, K. S. Cellular-scale sex differences in extracellular matrix remodeling by valvular interstitial cells. Heart Vessel. 38, 122\u2013130 (2023).","journal-title":"Heart Vessel."},{"key":"32038_CR48","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/CIRCULATIONAHA.121.054108","volume":"145","author":"BA Aguado","year":"2022","unstructured":"Aguado, B. A. et al. Genes that escape x chromosome inactivation modulate sex differences in valve myofibroblasts. Circulation 145, 513\u2013530 (2022).","journal-title":"Circulation"},{"key":"32038_CR49","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015610","volume":"9","author":"M Voisine","year":"2020","unstructured":"Voisine, M. et al. Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. JAHA 9, e015610 (2020).","journal-title":"JAHA"},{"key":"32038_CR50","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/cvr\/cvab142","volume":"118","author":"HZE Greenberg","year":"2022","unstructured":"Greenberg, H. Z. E., Zhao, G., Shah, A. M. & Zhang, M. Role of oxidative stress in calcific aortic valve disease and its therapeutic implications. Cardiovasc. Res. 118, 1433\u20131451 (2022).","journal-title":"Cardiovasc. Res."},{"key":"32038_CR51","doi-asserted-by":"publisher","first-page":"158183","DOI":"10.1172\/jci.insight.158183","volume":"8","author":"F Saaoud","year":"2023","unstructured":"Saaoud, F. et al. Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress\/mitochondrial ROS\/glycolysis pathways. JCI Insight 8, 158183 (2023).","journal-title":"JCI Insight"},{"key":"32038_CR52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fnmol.2020.00138","volume":"13","author":"M Govindarajulu","year":"2020","unstructured":"Govindarajulu, M. et al. Gut Metabolite TMAO Induces synaptic plasticity deficits by promoting endoplasmic reticulum stress. Front. Mol. Neurosci. 13, 138 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"32038_CR53","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3390\/cancers12061702","volume":"12","author":"YY Wang","year":"2020","unstructured":"Wang, Y. Y., Lee, K. T., Lim, M. C. & Choi, J. H. TRPV1 Antagonist DWP05195 Induces ER stress-dependent apoptosis through the ROS-p38-CHOP pathway in human ovarian cancer cells. Cancers (Basel) 12, 1702 (2020).","journal-title":"Cancers (Basel)"},{"key":"32038_CR54","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.cmet.2019.08.021","volume":"30","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Trimethylamine N-Oxide binds and activates PERK to promote metabolic dysfunction. Cell Metab. 30, 1141-1151.e5 (2019).","journal-title":"Cell Metab."},{"key":"32038_CR55","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1021\/jm300713s","volume":"55","author":"JM Axten","year":"2012","unstructured":"Axten, J. M. et al. Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase r (PKR)-like endoplasmic reticulum kinase (PERK). J. Med. Chem. 55, 7193\u20137207 (2012).","journal-title":"J. Med. Chem."},{"key":"32038_CR56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1021\/ml400228e","volume":"4","author":"JM Axten","year":"2013","unstructured":"Axten, J. M. et al. Discovery of GSK2656157: An optimized PERK inhibitor selected for preclinical development. ACS Med. Chem. Lett. 4, 964\u2013968 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"32038_CR57","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/cdd.2017.58","volume":"24","author":"D Rojas-Rivera","year":"2017","unstructured":"Rojas-Rivera, D. et al. When PERK inhibitors turn out to be new potent RIPK1 inhibitors: Critical issues on the specificity and use of GSK2606414 and GSK2656157. Cell Death Differ. 24, 1100\u20131110 (2017).","journal-title":"Cell Death Differ."},{"key":"32038_CR58","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41419-019-1523-3","volume":"10","author":"M Mahameed","year":"2019","unstructured":"Mahameed, M. et al. The unfolded protein response modulators GSK2606414 and KIRA6 are potent KIT inhibitors. Cell Death Dis. 10, 300 (2019).","journal-title":"Cell Death Dis."},{"key":"32038_CR59","doi-asserted-by":"publisher","first-page":"11880","DOI":"10.7554\/eLife.11880","volume":"5","author":"CM Gallagher","year":"2016","unstructured":"Gallagher, C. M. & Walter, P. Ceapins inhibit ATF6\u03b1 signaling by selectively preventing transport of ATF6\u03b1 to the Golgi apparatus during ER stress. Elife 5, 11880 (2016).","journal-title":"Elife"},{"key":"32038_CR60","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41371-022-00698-6","volume":"36","author":"SK Masenga","year":"2022","unstructured":"Masenga, S. K. et al. Recent advances in modulation of cardiovascular diseases by the gut microbiota. J. Hum. Hypertens. 36, 952\u2013959 (2022).","journal-title":"J. Hum. Hypertens."},{"key":"32038_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s43556-022-00091-2","volume":"3","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. The role of the gut microbiota in health and cardiovascular diseases. Mol. Biomed. 3, 30 (2022).","journal-title":"Mol. Biomed."},{"key":"32038_CR62","doi-asserted-by":"publisher","first-page":"H923","DOI":"10.1152\/ajpheart.00376.2019","volume":"317","author":"AF Ahmad","year":"2019","unstructured":"Ahmad, A. F., Dwivedi, G., O\u2019Gara, F., Caparros-Martin, J. & Ward, N. C. The gut microbiome and cardiovascular disease: Current knowledge and clinical potential. Am. J. Physiol. -Heart Circ. Physiol. 317, H923\u2013H938 (2019).","journal-title":"Am. J. Physiol. -Heart Circ. Physiol."},{"key":"32038_CR63","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WHW Tang","year":"2017","unstructured":"Tang, W. H. W., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circ. Res. 120, 1183\u20131196 (2017).","journal-title":"Circ. Res."},{"key":"32038_CR64","doi-asserted-by":"publisher","first-page":"15580","DOI":"10.1038\/s41598-019-52082-z","volume":"9","author":"C Roncal","year":"2019","unstructured":"Roncal, C. et al. Trimethylamine-N-Oxide (TMAO) predicts cardiovascular mortality in peripheral artery disease. Sci. Rep. 9, 15580 (2019).","journal-title":"Sci. Rep."},{"key":"32038_CR65","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ebiom.2019.03.066","volume":"44","author":"G Meng","year":"2019","unstructured":"Meng, G. et al. Gut microbe-derived metabolite trimethylamine N-oxide activates the cardiac autonomic nervous system and facilitates ischemia-induced ventricular arrhythmia via two different pathways. EBioMedicine 44, 656\u2013664 (2019).","journal-title":"EBioMedicine"},{"key":"32038_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/jvim.15347","volume":"33","author":"ET Karlin","year":"2019","unstructured":"Karlin, E. T., Rush, J. E. & Freeman, L. M. A pilot study investigating circulating trimethylamine N-oxide and its precursors in dogs with degenerative mitral valve disease with or without congestive heart failure. J. Vet. Intern. Med. 33, 46\u201353 (2019).","journal-title":"J. Vet. Intern. Med."},{"key":"32038_CR67","first-page":"449","volume":"20","author":"EL Monzack","year":"2011","unstructured":"Monzack, E. L. & Masters, K. S. Can valvular interstitial cells become true osteoblasts?: A side-by-side comparison. J. Heart Valve Dis. 20, 449\u2013463 (2011).","journal-title":"J. Heart Valve Dis."},{"key":"32038_CR68","doi-asserted-by":"publisher","first-page":"21338","DOI":"10.1038\/s41598-020-78507-8","volume":"10","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. Age related extracellular matrix and interstitial cell phenotype in pulmonary valves. Sci. Rep. 10, 21338 (2020).","journal-title":"Sci. Rep."},{"key":"32038_CR69","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/1573403X14666180820151325","volume":"14","author":"P Ohukainen","year":"2018","unstructured":"Ohukainen, P., Ruskoaho, H. & Rys\u00e4, J. Cellular mechanisms of valvular thickening in early and intermediate calcific aortic valve disease. Curr. Cardiol. Rev. 14, 264\u2013271 (2018).","journal-title":"Curr. Cardiol. Rev."},{"key":"32038_CR70","doi-asserted-by":"publisher","first-page":"9070","DOI":"10.1038\/s41598-024-58084-w","volume":"14","author":"K Stefania","year":"2024","unstructured":"Stefania, K., Ashok, K. K., Geena, P. V., Katarina, P. & Isak, D. TMAO enhances TNF-\u03b1 mediated fibrosis and release of inflammatory mediators from renal fibroblasts. Sci. Rep. 14, 9070 (2024).","journal-title":"Sci. Rep."},{"key":"32038_CR71","doi-asserted-by":"publisher","first-page":"11864","DOI":"10.3390\/ijms222111864","volume":"22","author":"S Kapetanaki","year":"2021","unstructured":"Kapetanaki, S., Kumawat, A. K., Persson, K. & Demirel, I. The fibrotic effects of TMAO on human renal fibroblasts is mediated by NLRP3, caspase-1 and the PERK\/Akt\/mTOR pathway. IJMS 22, 11864 (2021).","journal-title":"IJMS"},{"key":"32038_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964477","volume":"13","author":"D Zhou","year":"2022","unstructured":"Zhou, D., Zhang, J., Xiao, C., Mo, C. & Ding, B.-S. Trimethylamine-N-oxide (TMAO) mediates the crosstalk between the gut microbiota and hepatic vascular niche to alleviate liver fibrosis in nonalcoholic steatohepatitis. Front. Immunol. 13, 964477 (2022).","journal-title":"Front. Immunol."},{"key":"32038_CR73","doi-asserted-by":"publisher","first-page":"104669","DOI":"10.1016\/j.isci.2022.104669","volume":"5","author":"SJ Kim","year":"2022","unstructured":"Kim, S. J. et al. Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation. iScience 5, 104669 (2022).","journal-title":"iScience"},{"key":"32038_CR74","doi-asserted-by":"publisher","unstructured":"Myllyharju, J. Intracellular post-translational modifications of collagens. In Collagen: Primer in Structure, Processing and Assembly (eds Brinckmann, J., Notbohm, H. & M\u00fcller, P. K.) 115\u2013147 https:\/\/doi.org\/10.1007\/b103821 (Springer, Berlin, Heidelberg, 2005).","DOI":"10.1007\/b103821"},{"key":"32038_CR75","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.3390\/polym13162642","volume":"13","author":"R Naomi","year":"2021","unstructured":"Naomi, R., Ridzuan, P. M. & Bahari, H. Current Insights into collagen type I. Polymer 13, 2642 (2021).","journal-title":"Polymer"},{"key":"32038_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2025.214436","volume":"178","author":"S Hambardzumyan","year":"2026","unstructured":"Hambardzumyan, S., Kasper, J. Y. & del Campo, A. Quantification of collagen matrix deposition in 2D cell cultures: A comparative study of existing assays. Biomater. Adv. 178, 214436 (2026).","journal-title":"Biomater. Adv."},{"key":"32038_CR77","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1366","volume":"7","author":"T N\u00ed N\u00e9ill","year":"2024","unstructured":"N\u00ed N\u00e9ill, T. et al. In vitro and ex vivo screening of microRNA combinations with enhanced cell penetrating peptides to stimulate intervertebral disc regeneration. JOR Spine 7, e1366 (2024).","journal-title":"JOR Spine"},{"key":"32038_CR78","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.110.234237","volume":"108","author":"J-H Chen","year":"2011","unstructured":"Chen, J.-H. & Simmons, C. A. Cell-Matrix interactions in the pathobiology of calcific aortic valve disease: Critical roles for matricellular, matricrine, and matrix mechanics cues. Circ. Res. 108, 1510\u20131524 (2011).","journal-title":"Circ. Res."},{"key":"32038_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2021.07.009","volume":"161","author":"AJ Scott","year":"2021","unstructured":"Scott, A. J., Simon, L. R., Hutson, H. N., Porras, A. M. & Masters, K. S. Engineering the aortic valve extracellular matrix through stages of development, aging, and disease. J. Mol. Cell. Cardiol. 161, 1\u20138 (2021).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"32038_CR80","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.actbio.2016.03.007","volume":"36","author":"B Duan","year":"2016","unstructured":"Duan, B., Yin, Z., Hockaday Kang, L., Magin, R. L. & Butcher, J. T. Active tissue stiffness modulation controls valve interstitial cell phenotype and osteogenic potential in 3D culture. Acta Biomater. 36, 42\u201354 (2016).","journal-title":"Acta Biomater."},{"key":"32038_CR81","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.yjmcc.2016.03.004","volume":"94","author":"J Hjortnaes","year":"2016","unstructured":"Hjortnaes, J. et al. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation. J. Mol. Cell. Cardiol. 94, 13\u201320 (2016).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"32038_CR82","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.matbio.2010.09.001","volume":"30","author":"KJ Rodriguez","year":"2011","unstructured":"Rodriguez, K. J., Piechura, L. M. & Masters, K. S. Regulation of valvular interstitial cell phenotype and function by hyaluronic acid in 2-D and 3-D culture environments. Matrix Biol. 30, 70\u201382 (2011).","journal-title":"Matrix Biol."},{"key":"32038_CR83","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jbm.a.32187","volume":"90A","author":"KJ Rodriguez","year":"2009","unstructured":"Rodriguez, K. J. & Masters, K. S. Regulation of valvular interstitial cell calcification by components of the extracellular matrix. J. Biomed. Mater. Res. Part A 90A, 1043\u20131053 (2009).","journal-title":"J. Biomed. Mater. Res. Part A"},{"key":"32038_CR84","first-page":"E363","volume":"115","author":"AM Porras","year":"2017","unstructured":"Porras, A. M., Westlund, J. A., Evans, A. D. & Masters, K. S. Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease. Proc. Natl. Acad. Sci. 115, E363\u2013E371\u00a0(2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"32038_CR85","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.actbio.2019.07.046","volume":"97","author":"MN Monroe","year":"2019","unstructured":"Monroe, M. N., Nikonowicz, R. C. & Grande-Allen, K. J. Heterogeneous multi-laminar tissue constructs as a platform to evaluate aortic valve matrix-dependent pathogenicity. Acta Biomater. 97, 420\u2013427 (2019).","journal-title":"Acta Biomater."},{"key":"32038_CR86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13293-023-00530-x","volume":"14","author":"LJ Ward","year":"2023","unstructured":"Ward, L. J. et al. Coronary artery calcification and aortic valve calcification in patients with kidney failure: A sex-disaggregated study. Biol. Sex Differ. 14, 48 (2023).","journal-title":"Biol. Sex Differ."},{"key":"32038_CR87","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","volume":"120","author":"L Simard","year":"2017","unstructured":"Simard, L. et al. Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis. Circ. Res. 120, 681\u2013691 (2017).","journal-title":"Circ. Res."},{"key":"32038_CR88","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1161\/CIRCIMAGING.112.980052","volume":"6","author":"SR Aggarwal","year":"2013","unstructured":"Aggarwal, S. R. et al. Sex differences in aortic valve calcification measured by multidetector computed tomography in aortic stenosis. Circ Cardiovasc. Imag. 6, 40\u201347 (2013).","journal-title":"Circ Cardiovasc. Imag."},{"key":"32038_CR89","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s00380-016-0909-8","volume":"32","author":"S Masjedi","year":"2017","unstructured":"Masjedi, S., Lei, Y., Patel, J. & Ferdous, Z. Sex-related differences in matrix remodeling and early osteogenic markers in aortic valvular interstitial cells. Heart Vessel 32, 217\u2013228 (2017).","journal-title":"Heart Vessel"},{"key":"32038_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.736303","volume":"8","author":"V Nelson","year":"2021","unstructured":"Nelson, V. et al. Angiogenic secretion profile of valvular interstitial cells varies with cellular sex and phenotype. Front. Cardiovasc. Med. 8, 736303 (2021).","journal-title":"Front. Cardiovasc. Med."},{"key":"32038_CR91","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/clinchem\/hvae087","volume":"70","author":"G Almer","year":"2024","unstructured":"Almer, G. et al. Association of serum trimethylamine-n-oxide concentration from childhood to early adulthood with age and sex. Clin. Chem. 70, 1162\u20131171 (2024).","journal-title":"Clin. Chem."},{"key":"32038_CR92","doi-asserted-by":"crossref","unstructured":"F\u00e9lix V\u00e9lez, N. E., Tu, K., Guo, P., Reeves, R. R. & Aguado, B. A. Secreted cytokines from inflammatory macrophages modulate sex differences in valvular interstitial cells on hydrogel biomaterials. J. Biomed. Mater. Res. A. 113, e37885 (2025).","DOI":"10.1002\/jbm.a.37885"},{"key":"32038_CR93","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1039\/D2BM00844K","volume":"10","author":"BJ Vogt","year":"2022","unstructured":"Vogt, B. J., Peters, D. K., Anseth, K. S. & Aguado, B. A. Inflammatory serum factors from aortic valve stenosis patients modulate sex differences in valvular myofibroblast activation and osteoblast-like differentiation. Biomater. Sci. 10, 6341\u20136353 (2022).","journal-title":"Biomater. Sci."},{"key":"32038_CR94","doi-asserted-by":"publisher","first-page":"622","DOI":"10.3389\/fendo.2019.00622","volume":"10","author":"B Zhang","year":"2019","unstructured":"Zhang, B., Miller, V. M. & Miller, J. D. Influences of sex and estrogen in arterial and valvular calcification. Front. Endocrinol. (Lausanne) 10, 622 (2019).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"32038_CR95","doi-asserted-by":"publisher","first-page":"e21183","DOI":"10.1096\/fj.202001588RR","volume":"35","author":"W Hu","year":"2021","unstructured":"Hu, W. et al. Knockdown of estrogen-related receptor \u03b1 inhibits valve interstitial cell calcification in vitro by regulating heme oxygenase 1. Faseb J. 35, e21183 (2021).","journal-title":"Faseb J."},{"issue":"2","key":"32038_CR96","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0003-4975(02)04312-6","volume":"75","author":"B Jian","year":"2003","unstructured":"Jian, B., Narula, N., Li, Q., Iii, E. R. M. & Levy, R. J. Progression of aortic valve stenosis: tgf-\u24241 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann. Thorac. Surg. 75(2), 457\u2013465 (2003).","journal-title":"Ann. Thorac. Surg."},{"key":"32038_CR97","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.matbio.2005.06.007","volume":"24","author":"MC Cushing","year":"2005","unstructured":"Cushing, M. C., Liao, J.-T. & Anseth, K. S. Activation of valvular interstitial cells is mediated by transforming growth factor-\u03b21 interactions with matrix molecules. Matrix Biol. 24, 428\u2013437 (2005).","journal-title":"Matrix Biol."},{"key":"32038_CR98","doi-asserted-by":"publisher","first-page":"14680","DOI":"10.1038\/s41598-021-92779-8","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Untargeted metabolomics and transcriptomics identified glutathione metabolism disturbance and PCS and TMAO as potential biomarkers for ER stress in lung. Sci. Rep. 11, 14680 (2021).","journal-title":"Sci. Rep."},{"key":"32038_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.toxlet.2024.08.009","volume":"400","author":"B Yang","year":"2024","unstructured":"Yang, B. et al. Trimethylamine N-oxide induces non-alcoholic fatty liver disease by activating the PERK. Toxicol. Lett. 400, 93\u2013103 (2024).","journal-title":"Toxicol. Lett."},{"key":"32038_CR100","first-page":"49","volume":"73","author":"TY Cheng","year":"2024","unstructured":"Cheng, T. Y. et al. Short-chain fatty acid butyrate against TMAO activating endoplasmic-reticulum stress and PERK\/IRE1-axis with reducing atrial arrhythmia. J. Adv. Res. 73, 49\u2013560 (2024).","journal-title":"J. Adv. Res."},{"key":"32038_CR101","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","volume":"8","author":"X Chen","year":"2023","unstructured":"Chen, X., Shi, C., He, M., Xiong, S. & Xia, X. Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets. Sig.Transduct. Targ. Ther. 8, 352 (2023).","journal-title":"Sig.Transduct. Targ. Ther."},{"key":"32038_CR102","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2018.08.020","volume":"136","author":"VA Myasoedova","year":"2018","unstructured":"Myasoedova, V. A. et al. Novel pharmacological targets for calcific aortic valve disease: Prevention and treatments. Pharmacol. Res. 136, 74\u201382 (2018).","journal-title":"Pharmacol. Res."},{"key":"32038_CR103","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41569-023-00845-7","volume":"20","author":"L-HM Moncla","year":"2023","unstructured":"Moncla, L.-H.M., Briend, M., Boss\u00e9, Y. & Mathieu, P. Calcific aortic valve disease: Mechanisms, prevention and treatment. Nat. Rev. Cardiol. 20, 546\u2013559 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"32038_CR104","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1007\/s00210-021-02137-8","volume":"394","author":"T Suzuki","year":"2021","unstructured":"Suzuki, T., Yamashita, S., Hattori, K., Matsuda, N. & Hattori, Y. Impact of a long-term high-glucose environment on pro-inflammatory responses in macrophages stimulated with lipopolysaccharide. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 394, 2129\u20132139 (2021).","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"32038_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.micron.2021.103179","volume":"154","author":"A Loyola-Leyva","year":"2022","unstructured":"Loyola-Leyva, A., Alc\u00e1ntara-Quintana, L. E., Ter\u00e1n-Figueroa, Y. & Gonz\u00e1lez, F. J. In vitro effect of high glucose concentrations on erythrocyte morphology assessed by scanning electron microscopy. Micron 154, 103179 (2022).","journal-title":"Micron"},{"key":"32038_CR106","doi-asserted-by":"publisher","first-page":"791646","DOI":"10.3389\/fcvm.2021.791646","volume":"8","author":"S Ferrari","year":"2022","unstructured":"Ferrari, S. & Pesce, M. The complex interplay of inflammation, metabolism, epigenetics, and sex in calcific disease of the aortic valve. Front. Cardiovasc. Med. 8, 791646 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"32038_CR107","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002254","volume":"4","author":"AM Porras","year":"2015","unstructured":"Porras, A. M. et al. Development of aortic valve disease in familial hypercholesterolemic swine: Implications for elucidating disease etiology. J. Am. Heart Assoc. 4, e002254 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"32038_CR108","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.athoracsur.2006.10.026","volume":"83","author":"JN Clark-Greuel","year":"2007","unstructured":"Clark-Greuel, J. N. et al. Transforming growth factor-\u03b21 mechanisms in aortic valve calcification: Increased alkaline phosphatase and related events. Ann. Thorac. Surg. 83, 946\u2013953 (2007).","journal-title":"Ann. Thorac. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32038-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32038-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T23:06:28Z","timestamp":1769209588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32038-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32038"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32038-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2269"}}